November 2, 2022 by Chain Drug Review
CVS, Karen Lynch, Opioid, third quarter
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health easily beat analysts’ sales and earnings estimates for the third quarter and again raised its full year guidance. The company reported adjusted earnings per share $2.09 on revenue of $81.16 billion, which climbed 10% from a year earlier. Wall Street had expected adjusted EPS of $1.99 on revenue of $76.75
September 6, 2022 by Chain Drug Review
CVS Health, Karen Lynch, Signify Health
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health and Signify Health have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than
August 3, 2022 by Chain Drug Review
CVS, Karen Lynch, second quarter
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health easily beat analysts’ projections for second quarter sales and earnings, and raised its full-year profit outlook. The company posted adjusted earnings per share of $2.40, topping Wall Street’s average forecast of $2.17. Net income was $2.96 billion, or $2.23 per share, up from $2.79 billion, or $2.10 per share, a
May 3, 2022 by Chain Drug Review
CVS Health, Dr. Sree Chaguturu, Karen Lynch
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced Tuesday that has been named Dr. Sree Chaguturu executive vice president and chief medical officer effective immediately. Chaguturu will be responsible for advancing the highest possible clinical quality standards, increasing access to care, improving patient outcomes, and reducing overall health care costs across the enterprise. He will have direct
April 1, 2022 by Chain Drug Review
CVS, Karen Lynch
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health announced on Friday the release of its annual Environmental, Social and Governance (ESG) report Healthy 2030 detailing how the company is helping create a healthier and more sustainable world. “In 2021 we made significant progress towards our Healthy 2030 goals, with a particular focus on addressing health equity and protecting the environment,”
March 10, 2022 by Chain Drug Review
CVS Health, David Dorman, Karen Lynch, Roger Farah, Tony White
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health Corp. announced Thursday that David Dorman, independent chair of the board of directors of CVS Health, will retire at the end of his current term, effective with the annual meeting of stockholders to be held on May 11. In addition, the board has unanimously selected Roger Farah to succeed Dorman
March 1, 2022 by Chain Drug Review
Bryant University Women's Summit, CVS, Karen Lynch
Leading Headlines, Retail News
SMITHFIELD, R.I. — Karen Lynch, president and chief executive officer at CVS Health will receive the Kati C. Machtley Businesswoman of the Year Award and deliver the luncheon keynote address at the 25th Bryant University Women’s Summit on Wednesday April 27th. Keynote sessions for the morning and afternoon will be delivered by Nikkia Reveillac, Director of Consumer
January 10, 2022 by Jeffrey Woldt
CVS, CVS Health, Karen Lynch
January 10, 2022, Opinion
As Karen Lynch nears the end of her first year as president and chief executive officer of CVS Health, it’s clear that she is intent on extending the legacy of growth and innovation that has been a hallmark of the company for more than three decades. Speaking at CVS’ investor day in New York City
November 29, 2021 by Chain Drug Review
CVS Health, Karen Lynch
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — The following is attributed to Karen Lynch, CVS Health president and chief executive officer, following her participation in a White House supply chain meeting earlier today: “We’re seeing progress with port congestion and staffing levels as a result of the administration’s recent actions, and the outlook for maintaining stocked shelves improves each
November 18, 2021 by Chain Drug Review
CVS Health, Karen Lynch, Michelle Peluso
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced on Thursday several moves to support its strategy of making health care more affordable, accessible and convenient for consumers. Prem Shah has been named to the newly created role of chief pharmacy officer and will oversee the omnichannel pharmacy strategy, effective immediately. On January 1, 2022, Shah and Michelle Peluso
October 4, 2021 by Jeffrey Woldt
COVID-19, CVS, Karen Lynch
October 4, 2021, Opinion
An article in a recent edition of The Wall Street Journal about challenges caused by a shortfall of workers at CVS Health missed the forest for the trees, focusing on problems at a few of its more than 10,000 drug stores, while giving short shrift to the extraordinary contributions that CVS — like other retail
September 1, 2021 by Chain Drug Review
19th Annual Morgan Stanley Global Healthcare Conference, CVS Health, Karen Lynch
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — CVS Health announced on Wednesday that president and CEO Karen Lynch and executive vice president and president, CVS Caremark Dr. Alan Lotvin, will participate in a fireside chat with investors at the 19th Annual Morgan Stanley Global Healthcare Conference on September 14, 2021, at approximately 8:45 am ET.
June 29, 2021 by Chain Drug Review
Aetna, Karen Lynch, U.S. News & World Report
Business, Leading Headlines, Pharmacy
WASHINGTON — U.S. News & World Report, in collaboration with the Aetna Foundation, an independent, charitable and philanthropic affiliate of CVS Health, released on Tuesday the fourth annual Healthiest Communities rankings. This year’s rankings are accompanied by tools highlighting county-level COVID-19 vaccine rates and other pandemic data, as well as editorial explorations of equity and mental
May 18, 2021 by Chain Drug Review
CVS Health, Karen Lynch, Shawn Guertin
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health announced on Tuesday that it has appointed Shawn Guertin as executive vice president and chief financial officer, effective May 28. Guertin succeeds Eva Boratto, who is leaving the company after a successful 11-year career. “Shawn is an extraordinary leader with a proven track record of developing financial strategies to help companies